drugset

drugset / Trial / NCT06745336

Clinical Study of CS-001 As a Treatment for Canities (Grey Hair)

NCT06745336 ↗

Phase 3 Not yet recruiting 240 enrolled Applied Biology, Inc. Complex Science · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Clinical Study to Assess the Safety and Efficacy of CS-001 as a treatment for Canities (Grey Hair)

Timeline

Start: 2025-06-15
Primary completion: 2027-06-15
Completion: 2027-09-15

Publications

Background Singal A, Daulatabad D, Grover C. Graying severity score: A useful tool for evaluation of premature canities. Indian Dermatol Online J. 2016 May-Jun;7(3):164-7. doi: 10.4103/2229-5178.182372.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CS-001	Small molecule	—	Topical

Indications